Heart 1998;79:234-241 ( March )
Procedural and follow up results with a new balloon expandable stent in unselected lesions
a Centro Cuore Columbus,
Milan, Italy, b Shaare Zedek Medical Centre,
Jerusalem, Israel, c Washington Cardiology
Center, Washington, DC, USA, d Medinol
Lmt, Tel Aviv, Israel
Correspondence to: Dr C di Mario, Cardiac Catheterisation Laboratory, Centro Cuore Columbus, Via M Buonarroti 48, 20145 Milan, Italy. email: columbus{at}micronet.it
Accepted for publication 12 November 1997
Objective
To assess the clinical and
angiographic results of the first clinical application of a new
balloon expandable stent, the NIR stent, characterised by high
longitudinal flexibility and low profile before expansion, and by high
radial support and minimal recoil and shortening after expansion.
Design
Single centre survey of
unselected lesions in consecutive patients.
Setting
Tertiary referral centre.
Patients and lesions
93 stents of various length
(9, 16, and 32 mm) were implanted in 64 lesions in 41 patients. Twenty
lesions (31%) were longer than 15 mm, and 17 lesions (27%) were
located in vessels with a diameter smaller than 2.5 mm. Extreme
tortuosity of the proximal vessel was present in 15 lesions (23%). All
patients were treated with aspirin and ticlopidine. All lesions were
evaluated before and after treatment by quantitative angiography, and
in 47 lesions (75%) the stent expansion was also controlled by
intracoronary ultrasound. Clinical follow up was available in all
patients and angiographic follow up was performed in 53 lesions (84%),
at a mean (SD) interval of 5.4 (1.7) months.
Results
Deployment of the stent failed in
two lesions (3%). Minimum lumen diameter increased from 1.01 (0.54) mm to 2.94 (0.49) mm, and diameter stenosis decreased from
66(15)% to 7(11)%. There was one in-hospital non-Q wave myocardial
infarction, one sudden death after 40 days, and 17 target lesion
revascularisations (27%). Angiographic restenosis (
50% diameter
stenosis) was documented in 19 lesions (36% of all lesions with
angiographic follow up), with an average residual diameter stenosis of
43(21)% and minimum lumen diameter of 1.63 (0.74) mm. Restenosis was
more common in vessels with a reference diameter < 2.5 mm (45%) and
for lesions longer than 15 mm (46%).
Conclusions
The NIR stent could be used
successfully in most lesions, achieving optimal angiographic results
with very few in-hospital or subacute cardiac events. The angiographic
restenosis rate and need for target lesion revascularisation remained
high in this unfavourable lesion subset, especially in small vessels
and long lesions.
© 1998 by Heart
This article has been cited by other articles:
-
Wohrle, J, Al-Khayer, E, Grotzinger, U, Schindler, C, Kochs, M, Hombach, V, Hoher, M
(2001). Comparison of the heparin coated vs the uncoated Jostent(R)--no influence on restenosis or clinical outcome. Eur Heart J
22: 1808-1816
[Abstract] -
Pump, H., Möhlenkamp, S., Sehnert, C. A., Schimpf, S. S., Schmidt, A., Erbel, R., Grönemeyer, D. H. W., Seibel, R. M. M.
(2000). Coronary Arterial Stent Patency: Assessment with Electron-Beam CT. Radiology
214: 447-452
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
